Skip to main content

Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: A Workshop

Completed

Psychiatric illnesses - including major depressive disorder, anxiety disorder, posttraumatic stress disorder, and substance use disorders - are widely prevalent and represent a significant health care burden worldwide. For many affected people, existing treatments provide incomplete relief from disruptive and disabling symptoms. On March 29-30, 2022, this workshop will explore the therapeutic use of psychedelics and entactogens for these disorders. Speakers will discuss the current state of knowledge regarding mechanisms of action and clinical efficacy; considerations for research, clinical trial design, and regulatory approval; bioethical and legal issues; and opportunities to move the field forward.

Events

Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: A Workshop

  • March 29 - 30, 2022
  • Workshop
  • Past

BACKGROUND Psychiatric illnesses - such as major depressive disorder, anxiety disorder, substance abuse disorder, and post-traumatic stress disorder (PTSD) - are widely prevalent and represent a sign...

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.